Spots Global Cancer Trial Database for taxol (paclitaxel)
Every month we try and update this database with for taxol (paclitaxel) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | NCT01873326 | Germ Cell Tumor... | Paclitaxel Ifosfamide Cisplatin Mesna Bleomycin Etoposide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment | NCT00807573 | Lung Cancer | Paclitaxel Pemetrexed Bevacizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | NCT01873326 | Germ Cell Tumor... | Paclitaxel Ifosfamide Cisplatin Mesna Bleomycin Etoposide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility | NCT00617370 | Breast Cancer Adenocarcinoma ... | epirubicin, cyc... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 | NCT00820170 | Breast Cancer | Dasatinib and P... | 18 Years - 90 Years | Memorial Sloan Kettering Cancer Center | |
| Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC | NCT00449657 | Non Small Cell ... | Taxol (paclitax... Radiotherapy Carboplatin Gemcitabine | 18 Years - | Leo W. Jenkins Cancer Center | |
| Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT00736619 | HEAD & NECK Can... | Cetuximab, IMRT... | 18 Years - 100 Years | Memorial Sloan Kettering Cancer Center | |
| Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility | NCT00617370 | Breast Cancer Adenocarcinoma ... | epirubicin, cyc... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer | NCT01276041 | Breast Cancer | pertuzumab in c... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors | NCT01297452 | Solid Tumors | BKM120 days 1 -... BKM120 (days 1 ... BKM120 (days 1-... BKM120, Paclita... | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
